Management Team

Barry Mangum, PharmD

Senior Vice President, Pediatrics

Dr. Barry Mangum is a leader in pediatric clinical pharmacology and drug development and has been instrumental in developing multiple compounds for the care of children worldwide. His expertise is in neonatal pharmacology where he has excelled in understanding the pharmacology and pathophysiology of disease in the most vulnerable patients, the neonate.

He has an extensive background in neonatal and pediatric pharmacology and is the co-founder, co-author, and co-publisher of the leading drug dosing manual, NeoFax®: A Manual of Drugs Used in Neonatal Care. Dr. Mangum continues to be active in national and global leadership of pediatric clinical research as an educator and committee member of academic and pharmaceutical industry organizations. He has represented the interest of pediatric patients by chairing and speaking at meetings globally on the topic of neonatal pharmacology and legislative issues to support clinical research in children. Additionally, Dr. Mangum has recently completed serving a four-year appointment to the World Health Organization’s Expert Committee on the Selection and Use of Essential Medicines.

Dr. Mangum has served as an academic with appointments in the Schools of Medicine at Duke University and University of North Carolina-Chapel Hill as Associate Clinical Professor, Clinical Pharmacology and Associate Clinical Professor, Pediatrics. He is a graduate of The Medical University of South Carolina where he received his Doctorate in Pharmacy with special thesis emphasis on neonatal/pediatric pharmacology.